Inflammation and dysbiosis were the two most studied health conditions for probiotics related research between 2016 and 2020, according to a newly constructed database by a group of Hong Kong researchers.
Integrative medicine offers vast opportunities to improve the diagnosis and treatment of patients, but more randomised clinical trials, better quality control, and clearer health indications are required, according to veteran TCM researcher Professor...
Next Miracle Nutrient is opening its first retail outlet in Hong Kong selling its nicotinamide mononucleotide (NMN) supplement, with the firm also hoping it will serve as an ‘experience centre’ to educate the public on NMN.
Nicotinamide riboside (NR) supplement specialist Chromadex’s has posted strong regional and global FY2020 financials, but the firm has issued a warning of ‘concerning behaviour’ from some nicotinamide mononucleotide (NMN) brands, especially in China.
Infant formula powders inspected in Hong Kong said to contain similar nutritional composition can differ in price by nearly 100%, a report by the Consumer Council has claimed – but a closer look at their methodology appears they are not necessarily comparing...
Researchers at the Chinese University of Hong Kong (CUHK) are conducting three clinical studies to assess the effects of a probiotic formula on COVID-19 patients, people at higher-risk of contracting the virus, and the general population.
Australia’s health foods brands Caruso Natural Health and Juice Plus were recently fined for false claims and advertising breaches respectively, the Therapeutic Goods Administration (TGA) announced in a statement.
Hong Kong-based Jacobson Pharma Group is targeting the China and Taiwan markets for cognitive health growth where it is intending to launch two omega-3 based products - Smartfish Reflect and Smartfish Cream.
Here's a recap of our 10 most read nutrition stories in May, featuring nutraceutical advancements in India, probiotic innovations across APAC, and the latest regulatory, infant nutrition, and nutricosmetics news in China.
Infant formula firm Ausnutria Dairy has announced a 51.6% year-on-year growth in revenue to RMB2,582.4m for H1 2018, largely attributed to the continuous increase in the sales of its house-brand formula products.
"This wasn't a hostile takeover, there will be no dilution of what we do…in fact, most people won't be able to tell the difference," was how Life-Space boss Ben McHarg coolly summed up the second biggest ever Chinese acquisition of...